Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015
Eva Blozik,1–3 Roland Rapold,1 Klaus Eichler,4 Oliver Reich1 1Department of Health Sciences, Helsana Group, Zürich, Switzerland; 2Institute of General Practice, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3Division of General Practice, University Medical Center...
Guardado en:
Autores principales: | Blozik E, Rapold R, Eichler K, Reich O |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3df751455b154f16b92728a4192297c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A narrative review of psoriasis and multiple sclerosis: links and risks
por: Silfvast-Kaiser AS, et al.
Publicado: (2019) -
Dry eye disease ranking among common reasons for seeking eye care in a large US claims database
por: Bradley JL, et al.
Publicado: (2019) -
Multiple sclerosis international
Publicado: (2010) -
Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data
por: Simbrich A, et al.
Publicado: (2019) -
Real living with multiple sclerosis
Publicado: (1993)